Host |
Mouse |
Clone |
Y2/51 |
Format |
Purified |
Method |
FL, F, P |
Isotype |
Mouse IgG1 |
Immunogen |
PHA stimulated peripheral blood cells |
CD61 (Integrin beta3)
|
Zytomed Systems GmbH |
Y2/51 |
100 µg |
Purified |
RUO |
603-2368 |
-
|
Host |
Mouse |
Clone |
Y2/51 |
Format |
Purified |
Method |
FL, F, P, WB |
Isotype |
Mouse IgG1 |
Immunogen |
PHA stimulated peripheral blood cells |
CD61 (Integrin beta3)
|
Zytomed Systems GmbH |
Y2/51 |
200 µg |
Purified |
RUO |
603-2369 |
-
|
Host |
Mouse |
Clone |
AK-6 |
Format |
Purified |
Method |
F, P, WB, FL |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:500 - 1:2000 (P) |
Isotype |
Mouse IgG1 |
Immunogen |
Human platelet membrane glycoproteins |
CD62 (P-Selectin)
|
Zytomed Systems GmbH |
AK-6 |
200 µg |
Purified |
RUO |
603-1286 |
-
|
Host |
Mouse |
Clone |
AK-6 |
Format |
Purified |
Method |
FL, F, P, IF, WB |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:500 - 1:2000 (P) |
Isotype |
Mouse IgG1 |
Immunogen |
Human platelet membrane glycoproteins |
CD62 (P-Selectin)
|
Zytomed Systems GmbH |
AK-6 |
100 µg |
Purified |
RUO |
603-1287 |
-
|
Host |
Mouse |
Clone |
CL2/6 |
Format |
Purified |
Method |
F, FL, IF |
Isotype |
Mouse IgG2a |
CD62E (E-Selectin)
|
Zytomed Systems GmbH |
CL2/6 |
100 µg |
Purified |
RUO |
603-1294 |
-
|
Host |
Mouse |
Clone |
1.2B6 |
Format |
Purified |
Method |
FL |
Isotype |
Mouse IgG1 |
Immunogen |
Human E-Selectin (ELAM-1) |
CD62E /CD62P - FITC
|
Zytomed Systems GmbH |
1.2B6 |
100 µg |
Purified |
RUO |
603-1298C |
-
|
Host |
Mouse |
Clone |
NK-I/C3 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Melanoma |
Dilution |
1:100 - 1:200 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
CD63
|
Diagnostic Biosystems |
NK-I/C3 |
1 ml |
Concentrate |
CE/IVD |
MOB301 |
-
|
Host |
Mouse |
Clone |
NK-I/C3 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Melanoma |
Dilution |
1:100 - 1:200 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
CD63
|
Diagnostic Biosystems |
NK-I/C3 |
0.1 ml |
Concentrate |
CE/IVD |
MOB301-01 |
-
|
Host |
Mouse |
Clone |
NK-I/C3 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Melanoma |
Dilution |
1:100 - 1:200 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
CD63
|
Diagnostic Biosystems |
NK-I/C3 |
0.5 ml |
Concentrate |
CE/IVD |
MOB301-05 |
-
|
Host |
Mouse |
Clone |
80H3 |
Format |
Purified |
Method |
F, FL |
Isotype |
Mouse IgG1 |
Immunogen |
CML leukocytes |
CD66b
|
Zytomed Systems GmbH |
80H3 |
200 µg |
Purified |
RUO |
603-1320 |
-
|
Host |
Rabbit |
Clone |
SP251 |
Format |
Concentrate |
Method |
P, FL |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:100 |
Immunogen |
Synthetic peptide within Human CD68 aa 100-200 (internal sequence) |
Localization |
Cytoplasmic membrane |
CD68
|
Zytomed Systems GmbH |
SP251 |
1 ml |
Concentrate |
RUO |
503-5514 |
-
|
Host |
Mouse |
Clone |
PG-M1 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Fast Enzyme or other Enzymes |
Positive control |
Tonsil |
Dilution |
1:10 - 1:40 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD68
|
Diagnostic Biosystems |
PG-M1 |
1 ml |
Concentrate |
CE/IVD |
MOB094 |
-
|
Host |
Mouse |
Clone |
PG-M1 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Fast Enzyme or other Enzymes |
Positive control |
Tonsil |
Dilution |
1:10 - 1:40 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD68
|
Diagnostic Biosystems |
PG-M1 |
0.1 ml |
Concentrate |
CE/IVD |
MOB094-01 |
-
|
Host |
Mouse |
Clone |
PG-M1 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Fast Enzyme or other Enzymes |
Positive control |
Tonsil |
Dilution |
1:10 - 1:40 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD68
|
Diagnostic Biosystems |
PG-M1 |
0.5 ml |
Concentrate |
CE/IVD |
MOB094-05 |
-
|
Host |
Mouse |
Clone |
PG-M1 |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Fast Enzyme or other Enzymes |
Positive control |
Tonsil |
Dilution |
- |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD68
|
Diagnostic Biosystems |
PG-M1 |
6 ml |
Ready-to-use |
CE/IVD |
PDM065 |
-
|
Host |
Mouse |
Clone |
KP1 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Tonsil, lymph node, spleen. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Subcellular fraction of human alveolar macrophages |
Localization |
Cytoplasm |
CD68
|
Zeta Corporation |
KP1 |
1.0 ml |
Concentrate |
CE/IVD |
Z2071ML |
-
|
Host |
Mouse |
Clone |
KP1 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Tonsil, lymph node, spleen. |
Dilution |
- |
Isotype |
IgG1 /κ |
Immunogen |
Subcellular fraction of human alveolar macrophages |
Localization |
Cytoplasm |
CD68
|
Zeta Corporation |
KP1 |
7 ml |
Ready-to-use |
CE/IVD |
Z2071MP |
-
|
Host |
Mouse |
Clone |
KP1 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Tonsil, lymph node, spleen. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Subcellular fraction of human alveolar macrophages |
Localization |
Cytoplasm |
CD68
|
Zeta Corporation |
KP1 |
0.5 ml |
Concentrate |
CE/IVD |
Z2071MS |
-
|
Host |
Mouse |
Clone |
KP1 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Tonsil, lymph node, spleen. |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1 /κ |
Immunogen |
Subcellular fraction of human alveolar macrophages |
Localization |
Cytoplasm |
CD68
|
Zeta Corporation |
KP1 |
0.1 ml |
Concentrate |
CE/IVD |
Z2071MT |
-
|
Host |
Mouse |
Clone |
514H12 |
Format |
TCS |
Method |
F, P |
Pretreatment |
EDTA |
Positive control |
Tonsil |
Dilution |
1:40 - 1:80 |
Isotype |
Mouse IgG2a |
Immunogen |
Fusion protein corresponding to external domain of human CD68 |
CD68 (Macrosialin, Macrophage Antigen)
|
Zytomed Systems GmbH |
514H12 |
100 µl |
TCS |
RUO |
603-1332 |
-
|
Host |
Rat |
Clone |
FA-11 |
Format |
Purified |
Method |
FL |
Isotype |
Rat IgG2a |
CD68 (Macrosialin, Macrophage Antigen) - FITC
|
Zytomed Systems GmbH |
FA-11 |
50 µg |
Purified |
RUO |
603-1333C |
-
|
Host |
Mouse |
Clone |
Ki-M7 |
Format |
Purified |
Method |
FL |
Isotype |
Mouse IgG1 |
Immunogen |
Cell suspensions of human lymph node |
CD68 (Macrosialin, Macrophage Antigen) - FITC
|
Zytomed Systems GmbH |
Ki-M7 |
100 Tests |
Purified |
RUO |
603-1334C |
-
|
Host |
Mouse |
Clone |
H68.4 |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Bone marrow |
Dilution |
1:50 - 1:100 |
Isotype |
IgG1 |
Localization |
Cell membrane, cytoplasm |
CD71
|
Biocare Medical |
H68.4 |
0.1 ml |
Concentrate |
CD/IVD |
ACI3110A |
-
|
Host |
Mouse |
Clone |
H68.4 |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Bone marrow |
Dilution |
1:50 - 1:100 |
Isotype |
IgG1 |
Localization |
Cell membrane, cytoplasm |
CD71
|
Biocare Medical |
H68.4 |
0.5 ml |
Concentrate |
CD/IVD |
ACI3110B |
-
|
Host |
Mouse |
Clone |
H68.4 |
Format |
Ready-to-use |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Bone marrow |
Dilution |
- |
Isotype |
IgG1 |
Localization |
Cell membrane, cytoplasm |
CD71
|
Biocare Medical |
H68.4 |
6 ml |
Ready-to-use |
CD/IVD |
API3110AA |
-
|
Host |
Mouse |
Clone |
ZM136 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Spleen, bone marrow |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1/κ |
Immunogen |
Recombinant fragment of human TFRC receptor |
Localization |
Cytoplasm |
CD71
|
Zeta Corporation |
ZM136 |
1 ml |
Concentrate |
CE/IVD |
Z2685ML |
-
|
Host |
Mouse |
Clone |
ZM136 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Spleen, bone marrow |
Dilution |
- |
Isotype |
IgG1/κ |
Immunogen |
Recombinant fragment of human TFRC receptor |
Localization |
Cytoplasm |
CD71
|
Zeta Corporation |
ZM136 |
7 ml |
Concentrate |
CE/IVD |
Z2685MP |
-
|
Host |
Mouse |
Clone |
ZM136 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Spleen, bone marrow |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1/κ |
Immunogen |
Recombinant fragment of human TFRC receptor |
Localization |
Cytoplasm |
CD71
|
Zeta Corporation |
ZM136 |
0.5 ml |
Concentrate |
CE/IVD |
Z2685MS |
-
|
Host |
Mouse |
Clone |
ZM136 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Spleen, bone marrow |
Dilution |
1:100 - 1:200 |
Isotype |
IgG1/κ |
Immunogen |
Recombinant fragment of human TFRC receptor |
Localization |
Cytoplasm |
CD71
|
Zeta Corporation |
ZM136 |
0.1 ml |
Concentrate |
CE/IVD |
Z2685MT |
-
|
Host |
Mouse |
Clone |
LN-2 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD74
|
Diagnostic Biosystems |
LN-2 |
1 ml |
Concentrate |
CE/IVD |
MOB168 |
-
|
Host |
Mouse |
Clone |
LN-2 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD74
|
Diagnostic Biosystems |
LN-2 |
0.1 ml |
Concentrate |
CE/IVD |
MOB168-01 |
-
|
Host |
Mouse |
Clone |
LN-2 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD74
|
Diagnostic Biosystems |
LN-2 |
0.5 ml |
Concentrate |
CE/IVD |
MOB168-05 |
-
|
Host |
Mouse |
Clone |
LN-2 |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
- |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD74
|
Diagnostic Biosystems |
LN-2 |
6 ml |
Ready-to-use |
CE/IVD |
PDM033 |
-
|
Host |
Mouse |
Clone |
LN-1 |
Format |
Purified |
Method |
F, P, FL |
Pretreatment |
Trypsin, Pronase |
Positive control |
Human Tonsil |
Isotype |
Mouse IgM |
Immunogen |
Human lymphocytes and SU-DHL4 cell line |
CD75s
|
Zytomed Systems GmbH |
LN-1 |
1 ml |
Purified |
RUO |
603-1354 |
-
|
Host |
Mouse |
Clone |
HM57 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:15 - 1:30 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM57 |
1 ml |
Concentrate |
CE/IVD |
MOB118 |
-
|
Host |
Mouse |
Clone |
HM57 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:15 - 1:30 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM57 |
0.1 ml |
Concentrate |
CE/IVD |
MOB118-01 |
-
|
Host |
Mouse |
Clone |
HM57 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:15 - 1:30 |
Isotype |
Mouse IgG1 |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM57 |
0.5 ml |
Concentrate |
CE/IVD |
MOB118-05 |
-
|
Host |
Mouse |
Clone |
HM47/A9 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:75 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM47/A9 |
1 ml |
Concentrate |
CE/IVD |
MOB242 |
-
|
Host |
Mouse |
Clone |
HM47/A9 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:75 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM47/A9 |
0.1 ml |
Concentrate |
CE/IVD |
MOB242-01 |
-
|
Host |
Mouse |
Clone |
HM47/A9 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:25 - 1:75 |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM47/A9 |
0.5 ml |
Concentrate |
CE/IVD |
MOB242-05 |
-
|
Host |
Mouse |
Clone |
HM47/A9 |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
- |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM47/A9 |
6 ml |
Ready-to-use |
CE/IVD |
PDM125 |
-
|
Host |
Mouse |
Clone |
HM47/A9 |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
- |
Isotype |
Mouse IgG1 kappa |
Localization |
Cell Membrane |
CD79a
|
Diagnostic Biosystems |
HM47/A9 |
25 ml |
Ready-to-use |
CE/IVD |
PDM125-25 |
-
|
Host |
Rabbit |
Clone |
SP18 |
Format |
Ready-to-use |
Reactivity |
DG, PG, BV |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
- |
Isotype |
Rabbit IgG |
Localization |
Cell Membrane |
CD79a
|
Zytomed Systems GmbH |
SP18 |
6 ml |
Ready-to-use |
RUO |
RBG029 |
-
|
Host |
Rabbit |
Clone |
SP18 |
Format |
Concentrate |
Reactivity |
DG, PG, BV |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:100 - 1:200 |
Isotype |
Rabbit IgG |
Localization |
Cell Membrane |
CD79a
|
Zytomed Systems GmbH |
SP18 |
1 ml |
Concentrate |
RUO |
RBK029 |
-
|
Host |
Rabbit |
Clone |
SP18 |
Format |
Concentrate |
Reactivity |
DG, PG, BV |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Tonsil |
Dilution |
1:100 - 1:200 |
Isotype |
Rabbit IgG |
Localization |
Cell Membrane |
CD79a
|
Zytomed Systems GmbH |
SP18 |
0.5 ml |
Concentrate |
RUO |
RBK029-05 |
-
|
Host |
Mouse |
Clone |
MEM-233 |
Format |
Purified |
Method |
WB, IP, FL |
Isotype |
Mouse IgG1 |
CD80
|
Zytomed Systems GmbH |
MEM-233 |
100 µg |
Purified |
RUO |
603-1373 |
-
|
Host |
Rat |
Clone |
RM80 |
Format |
Purified |
Method |
F, FL |
Isotype |
Rat IgG2a |
Immunogen |
BCL1 cells expressing CD80 |
CD80
|
Zytomed Systems GmbH |
RM80 |
250 µg |
Purified |
RUO |
603-2340 |
-
|
Host |
Mouse |
Clone |
B-L2 |
Format |
Purified |
Method |
F, FL |
Isotype |
Mouse IgG1 |
Immunogen |
CD82 transfected murine mastocytoma cell line P815 |
CD82
|
Zytomed Systems GmbH |
B-L2 |
200 Tests |
Purified |
RUO |
603-1390 |
-
|
Host |
Mouse |
Clone |
BU63 |
Format |
Purified |
Method |
F, IP, FL |
Isotype |
Mouse IgG1 |
Immunogen |
Human peripheral blood lymphocytes |
CD86 (B7-2)
|
Zytomed Systems GmbH |
BU63 |
200 µg |
Purified |
RUO |
603-1396 |
-
|
Host |
Mouse |
Clone |
F15-42-1 |
Format |
Purified |
Method |
F, IP, FL |
Isotype |
Mouse IgG1 |
Immunogen |
Purified human brain Thy-1 |
CD90 (Thy-1)
|
Zytomed Systems GmbH |
F15-42-1 |
200 µg |
Purified |
RUO |
603-1435 |
-
|